Abstract

BackgroundProtein transduction is safer than viral vector-mediated transduction for the delivery of a therapeutic protein into a cell. Fusion proteins with an arginine-rich cell-penetrating peptide have been produced in E. coli, but the low solubility of the fusion protein expressed in E. coli impedes the large-scale production of fusion proteins from E. coli.ResultsExpressed protein ligation is a semisynthetic method to ligate a bacterially expressed protein with a chemically synthesized peptide. In this study, we developed expressed protein ligation-based techniques to conjugate synthetic polyarginine peptides to Cre recombinase. The conjugation efficiency of this technique was higher than 80%. Using this method, we prepared semisynthetic Cre with poly-L-arginine (ssCre-R9), poly-D-arginine (ssCre-dR9) and biotin (ssCre-dR9-biotin). We found that ssCre-R9 was delivered to the cell to a comparable level or more efficiently compared with Cre-R11 and TAT-Cre expressed as recombinant fusion proteins in E. coli. We also found that the poly-D-arginine cell-penetrating peptide was more effective than the poly-L-arginine cell-penetrating peptide for the delivery of Cre into cell. We visualized the cell transduced with ssCre-dR9-biotin using avidin-FITC.ConclusionsCollectively, the results demonstrate that expressed protein ligation is an excellent technique for the production of cell-permeable Cre recombinase with polyarginine cell-penetrating peptides. In addition, this approach will extend the use of cell-permeable proteins to more sophisticated applications, such as cell imaging.Electronic supplementary materialThe online version of this article (doi:10.1186/s12896-015-0126-z) contains supplementary material, which is available to authorized users.

Highlights

  • Protein transduction is safer than viral vector-mediated transduction for the delivery of a therapeutic protein into a cell

  • In this study, we devised an Expressed protein ligation (EPL)-based technique to conjugate synthetic polyarginine Cell-penetrating peptide (CPP) to Cre protein expressed in E. coli without impairing the enzymatic activity of Cre

  • The ligation product, ssCre-R9, exhibited comparable or even better transduction activity compared with the recombinant TAT-Cre and Cre-R11 fusion proteins directly expressed in E. coli

Read more

Summary

Introduction

Protein transduction is safer than viral vector-mediated transduction for the delivery of a therapeutic protein into a cell. Protein delivery is regarded as a safer and useful alternative to gene delivery for the induction of genome editing and alterations in the gene expression profile of cells. There is a slight possibility that a genome would be altered by proteins delivered directly into cells. Proteins become degraded and are eventually removed from cells. This property makes protein delivery more suitable for cell therapy applications in which a transient, rather than a sustained, action of transcription factors is required. Due to the impermeability of proteins through a nonpolar cell membrane, protein delivery typically requires a

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.